Market Access Views & Analysis

Views & Analysis

Market Access

Promoting value-added medicines and renovating old medicines...

In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.

Views & Analysis

JPM: Four ways FDA is seeking to buoy gene therapy

On the outskirts of the JP Morgan Healthcare Conference today, FDA's Dr Peter Marks discussed how to get more gene therapies approved in 2024.

Market Access

The race to develop innovative products and supply chain sol...

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and

Market Access

NICE and orphan drug recommendations: Should we be more worr...

Leela Barham uses the very latest data – running up to November 2023 – to take stock of NICE’s Single Technology Appraisal (STA) recommendations on orphan drugs versus non-orphans.

Market Access